Published in Clin Sci (Lond) on October 01, 1997
Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology (2002) 1.56
Mast cells in inflammatory arthritis. Arthritis Res Ther (2004) 1.21
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis. Arthritis Rheum (2013) 1.01
Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol (2011) 1.00
Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol (2014) 0.97
Mast cells in vulnerable atherosclerotic plaques--a view to a kill. J Cell Mol Med (2007) 0.96
Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms. World J Gastroenterol (2004) 0.91
Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol (2007) 0.90
Activation of human colon mast cells through proteinase activated receptor-2. World J Gastroenterol (2004) 0.84
Allosteric control of βII-tryptase by a redox active disulfide bond. J Biol Chem (2013) 0.83
Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens. J Immunol (2013) 0.82
Inhibition of tryptase release from human colon mast cells by protease inhibitors. World J Gastroenterol (2004) 0.81
The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis (2015) 0.80
Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann Rheum Dis (2001) 0.80
Histamine, histamine receptors (H1 and H2), and histidine decarboxylase expression by chondrocytes of osteoarthritic cartilage: an immunohistochemical study. Rheumatol Int (2005) 0.77
Effect of histamine on the production of matrix metalloproteinases-1, -3, -8 and -13, and TNFalpha and PGE(2) by human articular chondrocytes and synovial fibroblasts in vitro: a comparative study. Virchows Arch (2004) 0.76
Focal bone involvement in inflammatory arthritis: the role of IL17. Rheumatol Int (2015) 0.76
Mast cells as a target in the treatment of rheumatoid arthritis. Inflammopharmacology (1999) 0.76
Tryptase is a candidate autoantigen in rheumatoid arthritis. Immunology (2014) 0.75
Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5. J Biol Chem (2017) 0.75
Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review. Clin Rheumatol (2016) 0.75
Uncertainty, resource exploitation, and conservation: lessons from history. Science (1993) 5.37
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med (1999) 4.75
Endometriosis. N Engl J Med (1993) 4.38
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer (1998) 3.93
Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. J Biol Chem (1974) 3.84
Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet (2001) 3.84
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia (2009) 3.40
Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A (1986) 3.34
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol (1991) 2.88
Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ (1999) 2.64
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis (1972) 2.59
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem (1981) 2.37
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21
Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms. Clin Exp Allergy (2001) 2.15
Cloning and characterization of complementary DNA for human tryptase. J Clin Invest (1989) 2.12
Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther (2015) 2.01
Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol (1979) 2.01
Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol (1987) 2.00
Disruption of the telomerase catalytic subunit gene from Arabidopsis inactivates telomerase and leads to a slow loss of telomeric DNA. Proc Natl Acad Sci U S A (1999) 1.99
Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med (2001) 1.94
Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest (1997) 1.89
Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res (1998) 1.84
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem (1986) 1.79
Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem (1989) 1.79
Primary ovarian pregnancy successfully treated with methotrexate. Am J Obstet Gynecol (1992) 1.76
Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol (1981) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest (1996) 1.73
Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med (2001) 1.72
Structure and function of the chemical mediators of mast cells. Prog Allergy (1984) 1.71
The mesenteric circulation. Anatomy and physiology. Surg Clin North Am (1997) 1.71
Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy (2012) 1.66
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest (1995) 1.63
Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy (2001) 1.61
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol (1996) 1.57
Purification and subunit structure of deoxyribonucleic acid-dependent ribonucleic acid polymerase I from the mouse myeloma, MOPC 315. J Biol Chem (1974) 1.56
Reference ranges of bone mineral density for women in southern England: the impact of local data on the diagnosis of osteoporosis. Br J Radiol (1996) 1.55
Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis (1988) 1.52
Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy (1995) 1.49
Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol (1983) 1.44
The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy (1999) 1.43
Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest (1989) 1.42
Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol (1997) 1.41
Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest (1997) 1.39
Thrombocytosis associated with low-molecular-weight heparin. Ann Intern Med (1996) 1.39
Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol (1997) 1.38
Osteoarthritis of the hip and osteoporosis of the proximal femur. Ann Rheum Dis (1991) 1.38
A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther (1998) 1.38
Alterations in appendicular skeletal mass in patients with rheumatoid, psoriatic, and osteoarthropathy. Ann Rheum Dis (1988) 1.38
Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol (1987) 1.37
Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest (1990) 1.36
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Ann Oncol (2012) 1.36
Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic Biol Med (1999) 1.35
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis (1988) 1.35
Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer (2001) 1.34
Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol (1987) 1.34
Purification and subunit structure of deoxyribonucleic acid-dependent ribonucleic acid polymerase II from the mouse plasmacytoma, MOPC 315. J Biol Chem (1975) 1.33
Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med (2000) 1.32
GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res (1994) 1.32
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A (1993) 1.30
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS (2000) 1.30
Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. J Immunol (1985) 1.29
Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. J Allergy Clin Immunol (2000) 1.29
The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol (1985) 1.28
Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood (1992) 1.28
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med (1996) 1.27
Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol (1997) 1.26
Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother (2013) 1.25
Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology (1999) 1.25
Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun (1999) 1.23
Distribution of distinct vacA, cagA and iceA alleles in Helicobacter pylori in Hong Kong. Helicobacter (2001) 1.20
Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem (1997) 1.20
Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J (1987) 1.19
Markers of mast cell degranulation. Methods (1997) 1.19
Osteoarthritis of the hip joint and acetabular dysplasia in women. Ann Rheum Dis (1995) 1.19
Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. J Immunol (1981) 1.19
Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol (1990) 1.19
IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol (2001) 1.18
Distinct molecular structures of nuclear class I, II, and III DNA-dependent RNA polymerases. Proc Natl Acad Sci U S A (1975) 1.17
Encephalomyocarditis virus infection of mouse plasmacytoma cells. II. Effect on host RNA synthesis and RNA polymerases. J Virol (1974) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis (1992) 1.17
Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine. Br Med J (Clin Res Ed) (1982) 1.16
Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood (2001) 1.16
An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther (2001) 1.16
Genetic variation and pathogenicity of highly virulent porcine reproductive and respiratory syndrome virus emerging in China. Arch Virol (2009) 1.16
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol (2000) 1.15